Objective To investigate the clinical effect of calcium hydroxide in the treatment of dental pulp diseases. Methods The control group in the treatment of the conventional mummification agent, the study group used calcium hydroxide in the treatment process, compared the two groups of clinical curative effect, dental pulp disease patients the incidence of adverse reactions. Results The study group of dental pulp disease in patients with clinical total efficiency up to 92.00％, the control group of dental pulp disease in patients with clinical total effective rate was only 72.00％, the difference between the two groups was statistically significant(P<0.05).After the treatment of different measures, the incidence of adverse reactions in the study group (8.00％) was significantly lower than that in the control group(28.00％), the difference between the two groups was statistically significant (P<0.05). Conclusion The use of calcium hydroxide in the treatment of patients with dental pulp disease can significantly improve the clinical efficacy, and help to protect the quality of life of patients, physical and mental health.

Chondroitin sulfate (CS) is a sulfurated glycosaminoglycan, a major component of the extracellular matrix, widely distributed in skin, cartilage and vascular tissue. CS plays an important role in the physiological state regulation of articular cartilage, which affects tensile strength and elasticity of tissues by influencing aggrecan. Previous studies have shown that CS sulfate modification may be related to the growth and development disorders of cartilage tissue and the occurrence of osteoarticular diseases. At the same time, CS is also a common joint supplement, often used in the treatment of osteoarthritis and Kashin-Beck disease. In this paper, the research progress of CS sulfate modification characteristics in Kashin-Beck disease and osteoarthritis and the application of the preparation in the treatment of Kashin-Beck disease and osteoarthritis are reviewed, aiming to provide help for the investigation of the etiology of Kashin-Beck disease and the treatment of osteoarthritis and Kashin-Beck disease.

This paper reviews the status quo of recent years’ research on autophagy and damage of chondrocytes in Kashin-Beck disease （KBD） and osteoarthritis （OA）. PI3K/AKT signaling pathway and mTOR regulate the autophagy activity of chondrocytes. PI3K/AKT signaling pathway can promote the proliferation of chondrocytes and cause their damage by inhibiting their autophagy activity. This might play an important role in the occurrence and progression of bone and joint diseases such as KBD and OA， and provide scientific basis for revealing the pathogenesis and treatment plan of them.